Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Liabilities and Shareholders Equity (2024 - 2025)

Hinge Health's Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $744.8 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 10.62% year-over-year to $744.8 million; the TTM value through Dec 2025 reached $2.9 billion, up 327.99%, while the annual FY2025 figure was $744.8 million, 10.62% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $744.8 million at Hinge Health, down from $769.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $769.8 million in Q3 2025 and bottomed at $673.3 million in Q4 2024.